DerSarkissian M - Search Results

1

Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma.

DerSarkissian M, Cranmer H, Dabora J, Bocharova I, Cherepanov D, Cheng M, Bhak RH, Duh MS. DerSarkissian M, et al. Hematology. 2023 Dec;28(1):2156731. doi: 10.1080/16078454.2022.2156731. Hematology. 2023. PMID: 36607147

2

Author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627.

Young-Xu Y, Melsheimer R, Emond B, Lefebvre P, DerSarkissian M, Lax A, Nguyen C, Bhak RH, Wu M, Lin I. Young-Xu Y, et al. Among authors: dersarkissian m. Curr Med Res Opin. 2022 Dec;38(12):2237-2240. doi: 10.1080/03007995.2022.2139970. Epub 2022 Nov 7. Curr Med Res Opin. 2022. PMID: 36274636 No abstract available.

3

Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study.

Wang PF, Yee CW, Gorsh B, Zichlin ML, Paka P, Bhak RH, Boytsov N, Khanal A, Noman A, DerSarkissian M, Ferrante S, Duh MS. Wang PF, et al. Among authors: dersarkissian m. Leuk Lymphoma. 2023 Feb;64(2):398-406. doi: 10.1080/10428194.2022.2140284. Epub 2022 Nov 21. Leuk Lymphoma. 2023. PMID: 36408998

4

A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.

Bell CF, Huang SP, Yu LH, DerSarkissian M, Germain G, Concoff AL, Averell CM, Rubin B, Gu YM, Duh MS, Wallace DJ. Bell CF, et al. Among authors: dersarkissian m. Rheumatol Ther. 2023 Feb;10(1):261-274. doi: 10.1007/s40744-022-00509-x. Epub 2022 Dec 5. Rheumatol Ther. 2023. PMID: 36471198 Free PMC article.

5

Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.

Garvey WT, Cheng M, Ramasamy A, Smolarz BG, Park S, Kumar N, Kim N, DerSarkissian M, Bhak RH, Duh MS, Wu M, Hansen S, Young-Xu Y. Garvey WT, et al. Among authors: dersarkissian m. Popul Health Manag. 2023 Feb;26(1):72-82. doi: 10.1089/pop.2022.0227. Epub 2023 Feb 3. Popul Health Manag. 2023. PMID: 36735596

6

Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden.

Huang SP, DerSarkissian M, Gu YM, Duh MS, Wang MJ, Benson J, Vu J, Averell C, Bell CF. Huang SP, et al. Among authors: dersarkissian m. J Manag Care Spec Pharm. 2023 Apr;29(4):365-377. doi: 10.18553/jmcp.2023.29.4.365. J Manag Care Spec Pharm. 2023. PMID: 36989451 Free PMC article.

7

Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL).

Patel H, Wahlstrom SK, DerSarkissian M, Kunzweiler C, Castriota F, Chang R, Gu Y, Guo H, Duh MS, Ryan KJ. Patel H, et al. Among authors: dersarkissian m. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(6):651-658. doi: 10.1080/14737167.2023.2200167. Epub 2023 Apr 11. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37021518

8

Veterans Affairs Prostate Cancer Treatment Sequencing (VAPCaTS): A Real-World Evidence Study of Men with Metastatic Prostate Cancer.

Freedland SJ, De Hoedt AM, DerSarkissian M, Chang R, Satija A, Nguyen C, Park S, Aillaud A, Drea E, Duh MS, Polascik TJ, Szatrowski T. Freedland SJ, et al. Among authors: dersarkissian m. Urol Pract. 2021 Jan;8(1):112-118. doi: 10.1097/UPJ.0000000000000166. Epub 2020 May 29. Urol Pract. 2021. PMID: 37145440

9

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.

Roeker LE, DerSarkissian M, Ryan K, Chen Y, Duh MS, Wahlstrom SK, Hakre S, Yu L, Guo H, Mato AR. Roeker LE, et al. Among authors: dersarkissian m. Blood Adv. 2023 Aug 22;7(16):4291-4301. doi: 10.1182/bloodadvances.2023009739. Blood Adv. 2023. PMID: 37163361 Free PMC article.

10

Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective US Database Study.

DerSarkissian M, Gu YM, Duh MS, Benson J, Huang SP, Averell C, Vu J, Wang MJ, Bell CF. DerSarkissian M, et al. ACR Open Rheumatol. 2023 Jun;5(6):318-328. doi: 10.1002/acr2.11550. Epub 2023 May 24. ACR Open Rheumatol. 2023. PMID: 37226045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page